Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
JAMA
; 325(16): 1620-1630, 2021 04 27.
Article
in En
| MEDLINE
| ID: mdl-33734299
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oxygen Inhalation Therapy
/
Thrombosis
/
Extracorporeal Membrane Oxygenation
/
Enoxaparin
/
COVID-19
/
Anticoagulants
Type of study:
Clinical_trials
/
Etiology_studies
/
Prognostic_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
JAMA
Year:
2021
Document type:
Article
Affiliation country: